Among their many benefits in practice, ONS Guidelines™ arm oncology nurses with the evidence to advocate for their patients’ care, according to findings from a fall 2021 focus group ONS conducted with nurses practicing at all levels of direct care.

In response to the 2010 Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health, the Nurses on Boards Coalition launched an initiative to increase the number of nurses in decision-making leadership capacities with a goal to place 10,000 nurses on corporate, health-related, and other panels, boards, and commissions. Yet today, we still have more work to do to advance nurses into those positions and to educate the public about nurses’ role in providing high-quality, safe patient care.

Completing up to a year of pembrolizumab immunotherapy after surgical resection of stage IIB or IIC melanoma decreases patients’ risk for disease recurrence or death by 35%, according to study findings presented at the European Society for Medical Oncology 2021 annual meeting. The new findings led the U.S. Food and Drug Administration to expand its approval of pembrolizumab to use as adjuvant therapy in both adults and children aged 12 and older with early-stage melanoma.

Communication is central to an oncology nurse’s role—with patients and families, within the unit, and across interprofessional teams. The Joint Commission identified poor communication as a causative factor in 80% of medical errors, particularly during caregiving handoffs. Effective communication skills are both a science and an art, but oncology professionals can use a variety of tools and techniques to enhance their practice.

Rewind. I adjust the strap on my mask and pinch it tightly around my nose and move it just under my lower eyelashes to prevent my goggles from fogging. These days, I am grateful for the face cover as it hides the pallor from six months in and the dark circles from long hours and anxious sleep. I wait at the valet circle for my team. Another SOS text out to them this morning. All hands on deck.

In late December 2021, the Centers for Disease Control and Prevention (CDC) released updated COVID-19 guidance, shortening the recommended time for isolation for those who tested positive for COVID-19 to five days followed by five days of wearing a mask when around others. Organizations that advocate for the well-being of healthcare professionals, such as the American Nurses Association (ANA) voiced their concerns and urged national leaders to prioritize those on the frontlines.

Six years ago, I signed up for the marrow registry through the German Bone Marrow Donor Center, also known as DKMS, which is an international organization that hosts stem cell registry drives. In late 2021, I received the call that I was a fully matched donor for a patient with chronic myeloid leukemia. As a hematology and oncology clinical nurse specialist, I have seen how valuable the gift of stem cells can be for a patient with hematologic disease. I didn’t think twice about completing the donation process.

Overall trust of scientists and their research during the COVID-19 pandemic has increased by nine percentage points between 2018 and 2020, according to the results from the November 2021 Wellcome Global Monitor 2020: COVID-19 report.